Evidence map›Paper›PMID 36130252›Full record

ArticleInternational health2022

The interruption of transmission of onchocerciasis in Kaduna, Kebbi and Zamfara states, Nigeria: another milestone achievement.

Sunday Isiyaku, Michael Igbe, Suzie Madaki, Louise C Hamill, Patrick Ndongmo, William Adamani, Simon Bush, Joy Shu'aibu, Elizabeth Elhassan, Yisa Saka and 9 more

Open access · goldAbstract read
In one paragraph

Article in International health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Sunday IsiyakuSightsavers, Golf Course Road, P.O. Box 503, Kaduna, Nigeria.
Michael IgbeFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Suzie MadakiSightsavers, Golf Course Road, P.O. Box 503, Kaduna, Nigeria.ORCID 0000-0003-3067-9205
Louise C HamillSightsavers, 35 Perrymount Road, Haywards Heath, RH16 3BZ, UK.
Patrick NdongmoSightsavers, Derriere Laboratoire Meka, Bastos, Yaoundé, BP 4484, Cameroon.
William AdamaniSightsavers, Golf Course Road, P.O. Box 503, Kaduna, Nigeria.
Simon BushSightsavers, 35 Perrymount Road, Haywards Heath, RH16 3BZ, UK.
Joy Shu'aibuSightsavers, Golf Course Road, P.O. Box 503, Kaduna, Nigeria.
Elizabeth ElhassanSightsavers, Golf Course Road, P.O. Box 503, Kaduna, Nigeria.
Yisa SakaFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Chukwuma AnyaikeFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Nse Michael AkpanFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Akilah JoelFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Audrey NyiorFederal Ministry of Health, Abuja, FCT, Nigeria, P.M.B. 083, Garki Abuja, Nigeria.
Alhassan AbdullahiKaduna State Ministry of Health, P.O. Box 3547, Kaduna, Nigeria.
Attahiru AleiroKebbi State Ministry of Health, Birnin Kebbi, Nigeria.
Abdullahi LabboZamfara State Ministry of Health, Gusau, Nigeria.
Hayward Babale MafuyaiUniversity of Jos, P.M.B. 2084, 930001, Plateau, Nigeria.
Bertram E B NwokeImo State University, P.M.B. 2000, Owerri, Nigeria.
Federal Ministry of Health · NGSightsavers · GBImo State University · NGKaduna State University · NGNational Radiation Protection Agency of Cameroon · CMUniversity of Jos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMore than 40 million people live in onchocerciasis-endemic areas in Nigeria. For at least 19 y, mass drug administration (MDA) with ivermectin was implemented with at least 65% total population coverage in Kaduna, Kebbi and Zamfara states. Impact surveys done using skin biopsies yielded no infections. Serological and entomological assessments were undertaken to determine if onchocerciasis transmission had been interrupted and MDA could be stopped.

methodsThe presence of onchocerciasis-specific immunoglobulin G4 antibody was measured by enzyme=linked immunosorbent assay conducted on dried blood spots collected from 5- to 9-year-old children resident in each state. O-150 polymerase chain reaction testing of Simulium damnosum s.l. heads for Onchocerca volvulus DNA was done on black flies collected by human landing capture and Esperanza window traps.

resultsA total of 9078 children were surveyed across the three states. A total of 6139 vectors were collected from Kaduna state, 129 from Kebbi state and 2 from Zamfara state; all were negative. Kebbi and Zamfara states did thousands of hours of black fly catching and intensive river prospecting. The resulting low fly catch was due to a low fly population incapable of sustaining transmission.

conclusionOnchocerciasis transmission has been interrupted and the three states meet World Health Organization thresholds: seropositivity in children <0.1% and <1/2000 infective black flies with 95% confidence. The 2.2 million people in Kaduna state and 4 million in Kebbi and Zamfara states no longer need ivermectin for onchocerciasis.

Indexed as

OnchocerciasisSimuliidaeAnimalsChildChild, PreschoolHumansImmunoglobulinsImmunosorbentsIvermectinNigeriaImmunoglobulinsImmunosorbentsIvermectinblack fliesentomological assessmentonchocerciasisOv16 serological assessmentSimuliumstopping mass drug administration

Identifiers

PMID36130252
PMCPMC9492257
OpenAlexW4296704466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.